Related Experiment Video
Updated: Aug 13, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's
Sonir R Antonini1, Valérie Baldacchino, Johanne Tremblay
1Laboratory of Endocrine Pathophysiology, Research Centre, Hotel-Dieu du Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.
Objective:
The molecular mechanisms responsible for glucose-dependent insulinotrophic peptide receptor or gastric inhibitory polypeptide receptor (GIPR) ectopic expression and function in GIP-dependent Cushing's syndrome (CS) are still unknown. GIPR presumably acts, like the ACTH receptor (ACTHR), through the Gs protein/cyclic AMP/protein kinase A (PKA) pathway to stimulate steroidogenesis. We studied the expression of several genes involved in this pathway in the adrenal tissues of patients with GIP-dependent CS.
Design And Methods:
RNA was extracted from adrenal tissues from nine patients with GIP-dependent CS [seven ACTH-independent bilateral macronodular adrenal hyperplasia (AIMAH), two adenomas], two control whole adult adrenals, two fasciculata cell-enriched preparations from normal adrenals, seven patients with Cushing's disease (CD) and two normal pancreas. Multiplex reverse transcriptase polymerase chain reaction (RT-PCR) evaluated the expression of GIPR, ACTHR, SF-1, Nur77, DAX-1, CYP11A, 3beta-HSD, CYP21, CREB and CREM genes.
Results:
GIPR mRNA was overexpressed in all GIP-dependent cases. In normal adrenals and in the adrenal tissues from patients with CD, minimal amounts of GIPR mRNA were detected. ACTHR mRNA expression was observed in all GIP-dependent adrenal tissues. The expression of steroidogenic enzymes and some specific and ubiquitous transcription factors (TFs) involved in the ACTHR cascade was significantly reduced.
Conclusions:
Our results indicate that the expression of ACTHR and other genes located downstream in the ACTHR cascade, including steroidogenic enzymes genes and some transcription factors, are relatively suppressed in GIP-dependent CS. Although the expression of aberrant receptors plays an important role in steroidogenesis and initiation of cell proliferation, additional genetic events might occur, altering the activity of the ACTHR pathway.
Insights
Glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed in GIP-dependent Cushing's syndrome (CS). However, ACTH receptor (ACTHR) and downstream genes are suppressed, suggesting additional genetic events in CS pathogenesis.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Ectopic expression of glucose-dependent insulinotropic polypeptide receptor (GIPR) in GIP-dependent Cushing's syndrome (CS) is not well understood.
- The GIPR pathway is presumed to activate steroidogenesis via the Gs protein/cyclic AMP/protein kinase A (PKA) pathway, similar to the ACTH receptor (ACTHR).
Purpose of the Study:
- To investigate the molecular mechanisms of GIPR ectopic expression and function in GIP-dependent CS.
- To analyze the expression of genes in the Gs protein/cyclic AMP/PKA pathway within adrenal tissues of GIP-dependent CS patients.
Main Methods:
- RNA extracted from adrenal tissues of nine GIP-dependent CS patients (seven AIMAH, two adenomas), controls, and Cushing's disease (CD) patients.
- Multiplex RT-PCR used to evaluate expression of GIPR, ACTHR, SF-1, Nur77, DAX-1, CYP11A, 3beta-HSD, CYP21, CREB, and CREM genes.
Main Results:
- GIPR mRNA was significantly overexpressed in all GIP-dependent CS cases.
- ACTHR mRNA was detected in all GIP-dependent adrenal tissues.
- Expression of steroidogenic enzymes and transcription factors in the ACTHR cascade was significantly reduced.
Conclusions:
- GIPR is aberrantly expressed in GIP-dependent CS.
- ACTHR and downstream genes, including steroidogenic enzymes and transcription factors, are suppressed in GIP-dependent CS.
- Additional genetic events beyond aberrant receptor expression likely contribute to the altered ACTHR pathway activity in CS.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
GPCRs Regulate Adenylyl Cylase Activity
Two...
Insulin: The Receptor and Signaling Pathways
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Cell Specific Gene Expression
